| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | Kunkel Lori Anne Director | Sale | -10,000 | -16.16%51,884 | $34.54 | $345,351 | View SEC filing | |
| 2026-05-20 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | -5,000 | -16.67%25,000 | $39.79 | $198,971 | View SEC filing | |
| 2026-04-21 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | -5,000 | -16.67%25,000 | $47.67 | $238,352 | View SEC filing | |
| 2026-03-27 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | -40,000 | -61.54%25,000 | $35.10 | $1,404,024 | View SEC filing | |
| 2026-03-19 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | -5,000 | -16.67%25,000 | $27.76 | $138,800 | View SEC filing | |
| 2026-03-11 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | -40,000 | -54.44%25,000 | $30.07 | $1,202,638 | View SEC filing | |
| 2026-03-10 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | -10,000 | -16.39%51,000 | $29.58 | $295,839 | View SEC filing | |
| 2026-02-19 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale | -45,000 | -64.29%25,000 | $26.17 | $1,177,862 | View SEC filing | |
| 2026-02-19 | Heyman Richard A. Director | Sale | -1,230 | -5.15%22,647 | $26.18 | $32,196 | View SEC filing | |
| 2026-02-10 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | -5,000 | -0.67%740,188 | $29.04 | $145,219 | View SEC filing | |
| 2026-01-22 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | -20,000 | -2.61%745,188 | $26.75 | $535,099 | View SEC filing | |
| 2026-01-22 | Heyman Richard A. Director | Sale | -1,230 | -4.90%23,877 | $26.75 | $32,902 | View SEC filing | |
| 2026-01-13 | Patel Anish CHIEF OPERATING OFFICER | Sale | -48,300 | -18.34%215,011 | $27.99 | $1,351,762 | View SEC filing | |
| 2026-01-12 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | -132,500 | -14.76%765,188 | $26.23 | $3,476,014 | View SEC filing | |
| 2026-01-12 | Heyman Richard A. Director | Sale | -13,920 | -7.58%25,107 | $25.02 | $348,281 | View SEC filing | |
| 2025-12-23 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | -5,000 | -0.55%897,688 | $16.84 | $84,206 | View SEC filing | |
| 2025-12-10 | Patel Anish CHIEF OPERATING OFFICER | Sale | -6,663 | -2.47%263,311 | $21.02 | $140,073 | View SEC filing | |
| 2025-11-21 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | -12,500 | -1.37%902,688 | $22.33 | $279,155 | View SEC filing | |
| 2025-11-19 | Kintz Samuel PRESIDENT AND CEO | Sale | -12,500 | -1.38%890,392 | $21.82 | $272,739 | View SEC filing | |
| 2025-11-12 | Patel Anish CHIEF OPERATING OFFICER | Sale | -6,667 | -2.41%269,974 | $17.40 | $116,034 | View SEC filing | |
| 2025-10-22 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER | Sale | -12,500 | -1.35%915,188 | $22.08 | $276,025 | View SEC filing | |
| 2025-10-21 | Kintz Samuel PRESIDENT AND CEO | Sale | -12,500 | -1.37%902,892 | $21.33 | $266,654 | View SEC filing | |
| 2025-10-09 | Patel Anish CHIEF OPERATING OFFICER | Sale | -6,667 | -2.35%276,641 | $20.10 | $133,993 | View SEC filing | |
| 2025-10-01 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | -3,250 | -12.38%23,000 | $20.40 | $66,291 | View SEC filing | |
| 2025-09-30 | Kintz Samuel PRESIDENT AND CEO | Sale | -3,700 | -0.40%915,392 | $20.06 | $74,228 | View SEC filing |
1-25 of 220
